Full Text View
Tabular View
No Study Results Posted
Related Studies
Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence (CAMPRAL)
This study has been completed.
Study NCT00385268   Information provided by National Institute on Drug Abuse (NIDA)
First Received: October 6, 2006   Last Updated: December 8, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cocaine Dependence
Additional conditions recognized in this trial
Cocaine-Related Disorders
More general conditions related to this trial
Disorders of Environmental Origin
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
acamprosate
placebo
Cognitive Behavioral Therapy
Additional drug interventions recognized in this trial
Cocaine
More general drug interventions related to this trial
Alcohol Deterrents
Anesthetics
Anesthetics, Local
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)
University of Pennsylvania


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services